BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 5, 2007
View Archived Issues
Promising preclinical potential of REP-3123 to treat Clostridium difficile infections
Read More
Studies reveal further benefits of quadrivalent papillomavirus vaccination
Read More
MF59-adjuvanted H5N1 prepandemic vaccine well tolerated in adults and elderly
Read More
Reduction of biomarkers of bone resorption seen with AZD-0530 in cancer patients
Read More
AR-709 active against pneumococci, achieves high concentrations in human lungs
Read More
Novel fusion protein insulin analogue shows extended action and reduced risk of hypoglycemia
Read More
In vitro antiproliferative activity of 17-AAG in uveal melanoma
Read More
MRI reveals vascular response to MN-029 in cancer patients
Read More
Huya Bioscience licenses antiarrhythmic compound sulcardine
Read More
Metabasis HCC therapy assigned orphan medicinal product status in E.U.
Read More
CardioVascular BioTherapeutics' wound healing compound successfully completes phase I
Read More
Critical Therapeutics advances zileuton injection to phase II
Read More
NIH SBIR grant awarded to ISIS for RNAi-based drug discovery
Read More
Peptimmune's novel peptide copolymer enters phase I for MS
Read More
Tapestry commences phase II clinical evaluation of TPI-287 for advanced pancreatic cancer
Read More
Pharmasset commences combination study of R-7128 for HCV treatment
Read More
Nanobac gains option to Calgenex technology for atherosclerosis and prostatitis
Read More
New oral quinolone antibacterial agent Geninax launched in Japan
Read More
FDA accepts BLA for Cinryze and grants priority review
Read More
Recent Shionogi patent reports novel agents for cancer pain relief
Read More
New agents for inflammatory disorders claimed in recent patents
Read More
Once-yearly Aclasta approved in E.U. for postmenopausal osteoporosis
Read More
Novel therapeutic agents for neurological disorders disclosed in recent patents
Read More
Enzyme replacement therapy Elaprase receives approval in Japan
Read More
Recent patents disclose novel antipsychotic, antidepressive and anxiolytic agents
Read More
